Dr. Seth Thomas Cioffi is a pharmacist who is specialized in Pharmacotherapy in Newington, Connecticut. Patients can reach him at 555 Willard Ave, Pharmacy Department, Newington or contact him on 860-666-6951. Active license number of Dr. Seth Thomas Cioffi is 8691 for Pharmacotherapy in Connecticut. Dr. Seth Thomas Cioffi is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Seth Thomas Cioffi speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Seth Thomas Cioffi are as mentioned below.
NPI Number:
1629189667
NPI Enumeration Date:
31 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Seth Thomas Cioffi are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
8691
Connecticut
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
11 Country Side Dr, Rocky Hill, Connecticut
Zip:
06067-1075
Phone Number:
860-666-6951
Fax Number:
--
Patients can reach Dr. Seth Thomas Cioffi at 555 Willard Ave, Pharmacy Department, Newington, Connecticut or can call on phone at 860-666-6951.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.